Michel Detheux, Chief Executive Officer at iTeos Therapeutics, Inc. (ITOS), sold 11,733 shares at $28.16 ($330K) on 2021-09-23, disclosed to the SEC on 2021-09-27.
Open-market sale of $330k ITOS by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.16 | 5,322 | $150K | 45.4% |
| 2 | $28.16 | 5,322 | $150K | 45.4% |
| 3 | $28.02 | 1,089 | $31K | 9.2% |
| Total | $28.15 avg | 11,733 | $330K | 100% |
| Filing → |
| ITOS | SELL | 2022-04-19 | $732K | — | Filing → |
| ITOS | SELL | 2022-03-22 | $1.2M | — | Filing → |
| ITOS | SELL | 2022-02-24 | $977K | — | Filing → |